SCIE期刊Cardiovascular Therapeutics 2024/2025影響因子:3.404 (CARDIOVASC THER) (1755-5914). (CARDIAC & CARDIOVASCULAR SYSTEMS)

只看該作者 · 發(fā)表于 2025-3-21 18:15:26

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)影響因子

SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)影響因子@(心臟與心血管系統(tǒng))學(xué)科排名

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)總引論文

SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)總引論文@(心臟與心血管系統(tǒng))學(xué)科排名

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)影響因子

SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)總引頻次@(心臟與心血管系統(tǒng))學(xué)科排名

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)即時(shí)影響因子

SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)即時(shí)影響因子@(心臟與心血管系統(tǒng))學(xué)科排名

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)五年累積影響因子

SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)五年累積影響因子@(心臟與心血管系統(tǒng))學(xué)科排名

只看該作者 · 發(fā)表于 2025-3-21 21:18:47

Submitted on: 04 January 2024. Revised on: 23 April 2024. Accepted on: 13 May 2024. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-22 03:53:10

Submitted on: 19 December 2002. Revised on: 14 March 2003. Accepted on: 01 April 2003. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-22 04:47:13

Submitted on: 30 August 2012. Revised on: 15 November 2012. Accepted on: 27 December 2012. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-22 10:39:49

Submitted on: 13 September 2019. Revised on: 08 January 2020. Accepted on: 26 February 2020. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-22 14:53:46

Submitted on: 22 August 1999. Revised on: 08 December 1999. Accepted on: 02 February 2000. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-22 21:01:32

Submitted on: 14 November 2023. Revised on: 18 January 2024. Accepted on: 13 March 2024. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-23 00:15:52

Submitted on: 14 December 2010. Revised on: 15 February 2011. Accepted on: 04 April 2011. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-23 04:19:58

Submitted on: 08 March 2021. Revised on: 01 July 2021. Accepted on: 16 August 2021. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

只看該作者 · 發(fā)表于 2025-3-23 09:07:26

Submitted on: 25 July 2003. Revised on: 24 September 2003. Accepted on: 16 October 2003. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:18
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved